Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis

IntroductionFerroptosis is associated with multiple pathophysiological processes. Inhibition of ferroptosis has received much concern for some diseases. Nonetheless, there is no study comprehensively illustrating functions of ferroptosis-related genes (FRGs) in psoriasis.MethodsIn this study, FRGs t...

Full description

Bibliographic Details
Main Authors: Man-Ning Wu, Dong-Mei Zhou, Chun-Yan Jiang, Wei-Wen Chen, Jia-Chi Chen, Yue-Min Zou, Tao Han, Li-Jia-Ming Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1104462/full
_version_ 1797961488857563136
author Man-Ning Wu
Dong-Mei Zhou
Chun-Yan Jiang
Wei-Wen Chen
Jia-Chi Chen
Yue-Min Zou
Tao Han
Li-Jia-Ming Zhou
author_facet Man-Ning Wu
Dong-Mei Zhou
Chun-Yan Jiang
Wei-Wen Chen
Jia-Chi Chen
Yue-Min Zou
Tao Han
Li-Jia-Ming Zhou
author_sort Man-Ning Wu
collection DOAJ
description IntroductionFerroptosis is associated with multiple pathophysiological processes. Inhibition of ferroptosis has received much concern for some diseases. Nonetheless, there is no study comprehensively illustrating functions of ferroptosis-related genes (FRGs) in psoriasis.MethodsIn this study, FRGs together with psoriasis-associated data were obtained in Ferroptosis Database (FerrDb) and gene expression omnibus (GEO) database separately. This work identified altogether 199 psoriasis-associated DE-FRGs, and they were tightly associated with immunity and autophagy modulation. Thereafter, the present study utilized SVM-RFE and LASSO algorithms to identify NR5A2, CISD1, GCLC, PRKAA2, TRIB2, ABCC5, ACSF2, TIMM9, DCAF7, PEBP1, and MDM2 from those 199 DE-FRGs to be marker genes. As revealed by later functional annotation, the marker genes possibly had important effects on psoriasis through being involved in diverse psoriasis pathogenesis-related pathways such as cell cycle, toll-like receptor (TLR), chemokine, and nod-like receptor (NLR) pathways. Moreover, altogether 37 drugs that targeted 11 marker genes were acquired. Besides, based on CIBERSORT analysis, alterations of immune microenvironment in psoriasis cases were possibly associated with PRKAA2, PEBP1, CISD1, and ACSF2.DiscussionTaken together, this work established the diagnostic potency and shed more lights on psoriasis-related mechanism. More investigations are warranted to validate its value in diagnosing psoriasis before it is applied in clinic.
first_indexed 2024-04-11T00:59:01Z
format Article
id doaj.art-9032eea36a42445286ddf58d68c39bca
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T00:59:01Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9032eea36a42445286ddf58d68c39bca2023-01-04T19:33:51ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011310.3389/fimmu.2022.11044621104462Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasisMan-Ning WuDong-Mei ZhouChun-Yan JiangWei-Wen ChenJia-Chi ChenYue-Min ZouTao HanLi-Jia-Ming ZhouIntroductionFerroptosis is associated with multiple pathophysiological processes. Inhibition of ferroptosis has received much concern for some diseases. Nonetheless, there is no study comprehensively illustrating functions of ferroptosis-related genes (FRGs) in psoriasis.MethodsIn this study, FRGs together with psoriasis-associated data were obtained in Ferroptosis Database (FerrDb) and gene expression omnibus (GEO) database separately. This work identified altogether 199 psoriasis-associated DE-FRGs, and they were tightly associated with immunity and autophagy modulation. Thereafter, the present study utilized SVM-RFE and LASSO algorithms to identify NR5A2, CISD1, GCLC, PRKAA2, TRIB2, ABCC5, ACSF2, TIMM9, DCAF7, PEBP1, and MDM2 from those 199 DE-FRGs to be marker genes. As revealed by later functional annotation, the marker genes possibly had important effects on psoriasis through being involved in diverse psoriasis pathogenesis-related pathways such as cell cycle, toll-like receptor (TLR), chemokine, and nod-like receptor (NLR) pathways. Moreover, altogether 37 drugs that targeted 11 marker genes were acquired. Besides, based on CIBERSORT analysis, alterations of immune microenvironment in psoriasis cases were possibly associated with PRKAA2, PEBP1, CISD1, and ACSF2.DiscussionTaken together, this work established the diagnostic potency and shed more lights on psoriasis-related mechanism. More investigations are warranted to validate its value in diagnosing psoriasis before it is applied in clinic.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1104462/fullbioinformaticspsoriasisdiagnosticferroptosisimmune microenvironment
spellingShingle Man-Ning Wu
Dong-Mei Zhou
Chun-Yan Jiang
Wei-Wen Chen
Jia-Chi Chen
Yue-Min Zou
Tao Han
Li-Jia-Ming Zhou
Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
Frontiers in Immunology
bioinformatics
psoriasis
diagnostic
ferroptosis
immune microenvironment
title Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
title_full Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
title_fullStr Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
title_full_unstemmed Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
title_short Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
title_sort genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from psoriasis
topic bioinformatics
psoriasis
diagnostic
ferroptosis
immune microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1104462/full
work_keys_str_mv AT manningwu geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT dongmeizhou geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT chunyanjiang geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT weiwenchen geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT jiachichen geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT yueminzou geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT taohan geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis
AT lijiamingzhou geneticanalysisofpotentialbiomarkersandtherapeutictargetsinferroptosisfrompsoriasis